1、 HUANG S,LIU K,CHENG A,et al.SOCS proteins participate in the regulation of innate immune response caused by viruses[J].Front Immunol,2020(11):558341. HUANG S,LIU K,CHENG A,et al.SOCS proteins participate in the regulation of innate immune response caused by viruses[J].Front Immunol,2020(11):558341.
2、 WONG G L,MANORE S G,DOHENY D L,et al.STAT family of transcription factors in breast cancer:Pathogenesis and therapeutic opportunities and challenges[J].Semin Cancer Biol,2022,86(Pt 3):84-106. WONG G L,MANORE S G,DOHENY D L,et al.STAT family of transcription factors in breast cancer:Pathogenesis and therapeutic opportunities and challenges[J].Semin Cancer Biol,2022,86(Pt 3):84-106.
3、 LI C,ZHANG W,FANG T,et al.Identification of the prognostic value among suppressor of cytokine signaling family members in kidney renal clear cell carcinoma[J].Front Mol Biosci,2021(8):585000. LI C,ZHANG W,FANG T,et al.Identification of the prognostic value among suppressor of cytokine signaling family members in kidney renal clear cell carcinoma[J].Front Mol Biosci,2021(8):585000.
4、 SOBAH M L,LIONGUE C,WARD A C.SOCS proteins in immunity,inflammatory diseases,and immune-related cancer[J].Front Med,2021(8):727987. SOBAH M L,LIONGUE C,WARD A C.SOCS proteins in immunity,inflammatory diseases,and immune-related cancer[J].Front Med,2021(8):727987.
5、 STEWART K L,LEPHART E D.Overview of BPH:Symptom relief with dietary polyphenols,vitamins and phytochemicals by nutraceutical supplements with implications to the prostate microbiome[J].Int J Mol Sci,2023,24(6):5486. STEWART K L,LEPHART E D.Overview of BPH:Symptom relief with dietary polyphenols,vitamins and phytochemicals by nutraceutical supplements with implications to the prostate microbiome[J].Int J Mol Sci,2023,24(6):5486.
6、 STRAND D W,COSTA D N,FRANCIS F,et al.Targeting phenotypic heterogeneity in benign prostatic hyperplasia[J].Differentiation,2017(96):49-61. STRAND D W,COSTA D N,FRANCIS F,et al.Targeting phenotypic heterogeneity in benign prostatic hyperplasia[J].Differentiation,2017(96):49-61.
7、 OUYANG J,AN T,WANG Y,et al.Down-regulation of SOCS6:An unfavorable prognostic factor for gastrointestinal stromal tumor proven by survival analysis[J].Diagn Pathol,2021,16(1):113. OUYANG J,AN T,WANG Y,et al.Down-regulation of SOCS6:An unfavorable prognostic factor for gastrointestinal stromal tumor proven by survival analysis[J].Diagn Pathol,2021,16(1):113.
8、 YUAN D,WANG W,SU J,et al.SOCS6 functions as a tumor suppressor by inducing apoptosis and inhibiting angiogenesis in human prostate cancer[J].Curr Cancer Drug Targets,2018,18(9):894-904. YUAN D,WANG W,SU J,et al.SOCS6 functions as a tumor suppressor by inducing apoptosis and inhibiting angiogenesis in human prostate cancer[J].Curr Cancer Drug Targets,2018,18(9):894-904.
9、 LI J,DENG H,HU M,et al.Inhibition of non-small cell lung cancer(NSCLC)growth by a novel small molecular inhibitor of EGFR[J].Oncotarget,2015,6(9):6749-6761. LI J,DENG H,HU M,et al.Inhibition of non-small cell lung cancer(NSCLC)growth by a novel small molecular inhibitor of EGFR[J].Oncotarget,2015,6(9):6749-6761.
10、 LIN H Y,LAI R H,LIN S T,et al.Suppressor of cytokine signaling 6(SOCS6)promotes mitochondrial fission via regulating DRP1 translocation[J].Cell Death Differ,2013,20(1):139-153. LIN H Y,LAI R H,LIN S T,et al.Suppressor of cytokine signaling 6(SOCS6)promotes mitochondrial fission via regulating DRP1 translocation[J].Cell Death Differ,2013,20(1):139-153.
11、 YANG Z,HUANG S,ZHAO L.Suppressor of cytokine signaling 6 in cancer development and therapy:Deciphering its emerging and suppressive roles[J].Cytokine Growth Factor Rev,2022(64):21-32. YANG Z,HUANG S,ZHAO L.Suppressor of cytokine signaling 6 in cancer development and therapy:Deciphering its emerging and suppressive roles[J].Cytokine Growth Factor Rev,2022(64):21-32.
12、 SUN L,KE M,YIN M,et al.Extracellular vesicle-encapsulated microRNA-296-3p from cancer-associated fibroblasts promotes ovarian cancer development through regulation of the PTEN/AKT and SOCS6/STAT3 pathways[J].Cancer Sci,2024,115(1):155-169. SUN L,KE M,YIN M,et al.Extracellular vesicle-encapsulated microRNA-296-3p from cancer-associated fibroblasts promotes ovarian cancer development through regulation of the PTEN/AKT and SOCS6/STAT3 pathways[J].Cancer Sci,2024,115(1):155-169.
13、 WANG L,LI Y,HONG F,et al.Circ_0062491 alleviates LPS-induced apoptosis and inflammation in periodontitis by regulating miR-498/SOCS6 axis[J].Innate Immun,2022,28(5):174-184. WANG L,LI Y,HONG F,et al.Circ_0062491 alleviates LPS-induced apoptosis and inflammation in periodontitis by regulating miR-498/SOCS6 axis[J].Innate Immun,2022,28(5):174-184.
14、 de NUNZIO C,KRAMER G,MARBERGER M,et,al.The controversial relationship between benign prostatic hyperplasia and prostate cancer:The role of inflammation[J].Eur Urol,2011,60(1):106-117. de NUNZIO C,KRAMER G,MARBERGER M,et,al.The controversial relationship between benign prostatic hyperplasia and prostate cancer:The role of inflammation[J].Eur Urol,2011,60(1):106-117.
15、 GANDAGLIA G,BRIGANTI A,GONTERO P,et al.The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia(BPH)[J].BJU Int,2013,112(4):432-441. GANDAGLIA G,BRIGANTI A,GONTERO P,et al.The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia(BPH)[J].BJU Int,2013,112(4):432-441.
16、 ALGABA F.Pathophysiology of benign prostatic hyperplasia[J].Eur Urol,1994,25(Suppl 1):3-5. ALGABA F.Pathophysiology of benign prostatic hyperplasia[J].Eur Urol,1994,25(Suppl 1):3-5.
17、 DONNELL R F.Benign prostate hyperplasia:A review of the year's progress from bench to clinic[J].Curr Opin Urol,2011,21(1):22-26. DONNELL R F.Benign prostate hyperplasia:A review of the year's progress from bench to clinic[J].Curr Opin Urol,2011,21(1):22-26.
18、 GBD Benign Prostatic Hyperplasia Collaborators.The global,regional,and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019:A systematic analysis for the Global Burden of Disease Study 2019[J].Lancet Healthy Longev,2022,3(11):e754-e776. GBD Benign Prostatic Hyperplasia Collaborators.The global,regional,and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019:A systematic analysis for the Global Burden of Disease Study 2019[J].Lancet Healthy Longev,2022,3(11):e754-e776.
